Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes.

scientific article

Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0092-8674(93)90275-U
P698PubMed publication ID8098995

P50authorStanley B. PrusinerQ155380
Stephen J DeArmondQ63437608
P2093author name stringScott M
Groth D
Torchia M
Foster D
Yang SL
P2860cites workMeasurement of the scrapie agent using an incubation time interval assayQ34270376
Molecular biology of prion diseasesQ34534878
Chimeric prion protein expression in cultured cells and transgenic miceQ36277480
Three hamster species with different scrapie incubation times and neuropathological features encode distinct prion proteinsQ36721451
Evidence that the Transmission of One Source of Scrapie Agent to Hamsters Involves Separation of Agent Strains from a MixtureQ39601572
Normal development and behaviour of mice lacking the neuronal cell-surface PrP proteinQ43522858
Predicted secondary structure and membrane topology of the scrapie prion proteinQ44073197
Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology, and pathogenesisQ44519112
Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques.Q45962479
Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamstersQ45968309
Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication.Q45979200
Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing.Q46025414
Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteinsQ46079042
Scrapie prions aggregate to form amyloid-like birefringent rodsQ46201693
Further purification and characterization of scrapie prionsQ46764657
Biological evidence that scrapie agent has an independent genomeQ48251939
Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopyQ48674139
Encephalopathy in mice produced by inoculation with scrapie brain material.Q51301574
Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent.Q52754778
The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in miceQ69226275
Linkage of prion protein and scrapie incubation time genesQ70143866
Monoclonal antibodies to the cellular and scrapie prion proteinsQ70299710
Temporary and permanent modifications to a single strain of mouse scrapie on transmission to rats and hamstersQ70345462
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectprion protein familyQ24724413
P304page(s)979-988
P577publication date1993-06-01
P1433published inCellQ655814
P1476titlePropagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes.
P478volume73

Reverse relations

cites work (P2860)
Q38290309A Mutant Prion Protein Displays an Aberrant Membrane Association When Expressed in Cultured Cells
Q45939477A change in the conformation of prions accompanies the emergence of a new prion strain.
Q43109950A glycolipid-anchored prion protein is endocytosed via clathrin-coated pits.
Q33968102A molecular switch controls interspecies prion disease transmission in mice
Q35122347A murine model of a familial prion disease.
Q33967861A protease-resistant 61-residue prion peptide causes neurodegeneration in transgenic mice
Q35852143A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.
Q34454961A transmembrane form of the prion protein in neurodegenerative disease
Q48550880A wild-type prion protein does not acquire properties of the scrapie isoform when coexpressed with a mutant prion protein in cultured cells
Q36663046Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies
Q48775242Abnormalities in stress proteins in prion diseases
Q33366539Accelerated high fidelity prion amplification within and across prion species barriers.
Q33813167Affinity-tagged miniprion derivatives spontaneously adopt protease-resistant conformations
Q48168864Amino acid sequence of the Felis catus prion protein
Q37184755Amyloidogenesis of natively unfolded proteins
Q38439914Animal models for prion-like diseases.
Q46161882Antibodies inhibit prion propagation and clear cell cultures of prion infectivity
Q39365772Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers
Q24635252Asymptomatic deer excrete infectious prions in faeces
Q27666974Atomic Structures Suggest Determinants of Transmission Barriers in Mammalian Prion Disease
Q37252008Biaryl amides and hydrazones as therapeutics for prion disease in transgenic mice
Q51284198Biology and Genetics of PrP Prion Strains.
Q24529092Branched polyamines cure prion-infected neuroblastoma cells
Q60068724Catching the culprit prion
Q40061707Cell Biology Approaches to Studying Prion Diseases
Q33558398Cellular biology of prion diseases
Q33937043Cerebral amyloidosis in prion diseases
Q28359731Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers
Q33405664Characteristics of 263K scrapie agent in multiple hamster species
Q35194921Characterization of Syrian hamster adapted prions derived from L-type and C-type bovine spongiform encephalopathies
Q42649627Characterization of a prion protein (PrP) gene from rabbit; a species with apparent resistance to infection by prions
Q37006731Chimeric elk/mouse prion proteins in transgenic mice
Q36235271Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform
Q47158648Chronic wasting disease (CWD) in cervids
Q33248701Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.
Q36782262Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans
Q43106197Conformation determines the seeding potencies of native and recombinant Tau aggregates
Q35376718Conformational transformation and selection of synthetic prion strains
Q33449340Conversion efficiency of bank vole prion protein in vitro is determined by residues 155 and 170, but does not correlate with the high susceptibility of bank voles to sheep scrapie in vivo
Q24564014Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins
Q36892999Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection?
Q37627076De novo mammalian prion synthesis
Q41478736Deadly conformations--protein misfolding in prion disease
Q44448848Deletion of N-terminal residues 23-88 from prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/doppel-induced Neurodegeneration
Q33847297Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform
Q40096957Destabilizing polymorphism in cervid prion protein hydrophobic core determines prion conformation and conversion efficiency
Q48002520Different behavior toward bovine spongiform encephalopathy infection of bovine prion protein transgenic mice with one extra repeat octapeptide insert mutation.
Q41298105Double replacement gene targeting for the production of a series of mouse strains with different prion protein gene alterations
Q41461364Effect of Q211 and K222 PRNP Polymorphic Variants in the Susceptibility of Goats to Oral Infection With Goat Bovine Spongiform Encephalopathy
Q33840809Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.
Q28540614Elements modulating the prion species barrier and its passage consequences
Q35034201Epigenetic dominance of prion conformers
Q35795039Etiology and pathogenesis of prion diseases.
Q36581272Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation
Q43785458Expression and targeting of Syrian hamster prion protein induced by heat shock in transgenic Drosophila melanogaster
Q40854367Expression of unglycosylated mutated prion protein facilitates PrP(Sc) formation in neuroblastoma cells infected with different prion strains
Q27348644Fatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob disease
Q35035428Fundamentals of prion biology and diseases
Q40075626Generation of a new infectious recombinant prion: a model to understand Gerstmann-Sträussler-Scheinker syndrome
Q40624569Genetics of prion diseases and prion diversity in mice
Q41689443Genetics of prions
Q28365495Glycosylation influences cross-species formation of protease-resistant prion protein
Q37079425H-type bovine spongiform encephalopathy: complex molecular features and similarities with human prion diseases
Q46113920Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an α-helix
Q36624152Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells
Q51793976Highly promiscuous nature of prion polymerization.
Q42693681Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie
Q72356037Human prion diseases
Q30639674Human prion protein sequence elements impede cross-species chronic wasting disease transmission.
Q36806018Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice
Q28511061Identification of candidate proteins binding to prion protein
Q33201341Identification of two immunogenic domains of the prion protein--PrP--which activate class II-restricted T cells and elicit antibody responses against the native molecule.
Q33836445Identification of two prion protein regions that modify scrapie incubation time
Q35641189Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein
Q34358708Influence of Mabs on PrP(Sc) formation using in vitro and cell-free systems
Q35251034Inherited prion diseases
Q40071080Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases
Q34974440Insights into the role of the immune system in prion diseases
Q35750568Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers
Q48963662Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice
Q39250023Lysosomal Quality Control in Prion Diseases
Q30424667Mammalian prions: tolerance to sequence changes-how far?
Q34046721Manipulating the Prion Protein Gene Sequence and Expression Levels with CRISPR/Cas9.
Q33281952Mapping of possible prion protein self-interaction domains using peptide arrays
Q37329528Measuring prions by bioluminescence imaging
Q31161627Molecular Mechanisms of Chronic Wasting Disease Prion Propagation
Q41627077Molecular and Biological Compatibility with Host Alpha-Synuclein Influences Fibril Pathogenicity
Q83323734Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies
Q42730560Molecular basis for transmission barrier and interference between closely related prion proteins in yeast
Q44833529Molecular basis of barriers for interspecies transmissibility of mammalian prions
Q40624601Molecular biology and genetics of prion diseases
Q46007757Molecular properties of complexes formed between the prion protein and synthetic peptides.
Q34467477Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform
Q36282275N-terminally tagged prion protein supports prion propagation in transgenic mice
Q27625390NMR structure of the bovine prion protein
Q27640537NMR structure of the human doppel protein
Q33582070Neurodegeneration in humans caused by prions
Q48308927Neurological illness in transgenic mice expressing a prion protein with an insertional mutation.
Q41549744Of mice and (mad) cows--transgenic mice help to understand prions
Q46894080Pathologic conformations of prion proteins
Q35122315Perspectives on prion biology, prion disease pathogenesis, and pharmacologic approaches to treatment
Q34628763Pharmacological approaches to prion research
Q26823798Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs)
Q54528615Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells.
Q42662000Polymorphism of prion protein gene in Arctic fox (Vulpes lagopus).
Q41607167Prion diseases and the BSE crisis
Q35602374Prion diseases: from molecular biology to intervention strategies
Q36356816Prion domains: sequences, structures and interactions
Q35523444Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice
Q34294957Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein
Q33761104Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform
Q33604091Prion protein and species barriers in the transmissible spongiform encephalopathies
Q34304971Prion protein conversion in vitro
Q54037114Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice.
Q34304955Prion protein diversity and disease in the transmissible spongiform encephalopathies
Q33962285Prion protein genes and prion diseases: studies in transgenic mice
Q37373871Prion protein misfolding and disease
Q41618801Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice
Q40537035Prion protein transgenes and the neuropathology in prion diseases
Q39409269Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C).
Q37036816Prion replication elicits cytopathic changes in differentiated neurosphere cultures
Q24633319Prions
Q48220367Prions and related neurological diseases
Q40372882Prions, beta-sheets and transmissible dementias: is there still something missing?
Q36548578Propagation of prion strains through specific conformers of the prion protein
Q37221670Recombinant human prion protein inhibits prion propagation in vitro
Q37096971Recombinant scrapie-like prion protein of 106 amino acids is soluble
Q34474868Review: contribution of transgenic models to understanding human prion disease.
Q37922607Role of metal ions in aggregation of intrinsically disordered proteins in neurodegenerative diseases
Q40139360Scrapie infection of prion protein-deficient cell line upon ectopic expression of mutant prion proteins
Q33930771Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody
Q46879245Scrapie prions: a three-dimensional model of an infectious fragment
Q42957132Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice.
Q30482741Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease
Q42367749Species-dependent structural polymorphism of Y145Stop prion protein amyloid revealed by solid-state NMR spectroscopy
Q33816387Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence
Q34306690Spongiform encephalopathies: insights from transgenic models
Q24641822Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice
Q44208453Structural and functional analysis of the ovine laminin receptor gene (RPSA): Possible involvement of the LRP/LR protein in scrapie response.
Q34322278Structural clues to prion replication
Q36055574Structure of the β2-α2 loop and interspecies prion transmission
Q54046641Synaptic prion protein immuno-reactivity in the rodent cerebellum.
Q43057853Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt-Jakob Disease
Q36020398Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept
Q42279018The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition
Q33408170The comprehensive native interactome of a fully functional tagged prion protein
Q33705857The genetics of prions--a contradiction in terms?
Q48629277The key must fit: macrophages transport prion infection to the central nervous system and may determine the sites of infection within it.
Q44437817The major species specific epitope in prion proteins of ruminants
Q35874348The prion protein gene is dispensable for the development of spongiform myeloencephalopathy induced by the neurovirulent Cas-Br-E murine leukemia virus
Q36731455The reconstitution of mammalian prion infectivity de novo
Q36319802The risk of transmission of variant Creutzfeldt-Jakob disease via contact lenses and ophthalmic devices
Q38492754The transmissible spongiform encephalopathies of livestock
Q92460612Thermostability as a highly dependent prion strain feature
Q57825820Three-dimensional NMR structure of a self-folding domain of the prion protein PrP(121–231)
Q34305023Three-dimensional structures of prion proteins
Q35037396Transgenesis applied to transmissible spongiform encephalopathies
Q40954169Transgenetics and neuropathology of prion diseases.
Q40975176Transgenetics of prion diseases.
Q48357484Transgenic and knockout mice in research on prion diseases
Q48715592Transgenic mice expressing bovine PrP with a four extra repeat octapeptide insert mutation show a spontaneous, non-transmissible, neurodegenerative disease and an expedited course of BSE infection.
Q58270048Transgenic mice in amyloid research: an interpretive review
Q34304996Transgenic studies of the influence of the PrP structure on TSE diseases.
Q33754930Transmission barriers for bovine, ovine, and human prions in transgenic mice
Q35823555Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein
Q35024303Transmission of elk and deer prions to transgenic mice
Q37596459Transmission of prions from mule deer and elk with chronic wasting disease to transgenic mice expressing cervid PrP.
Q33580805Transmission of scrapie and sheep-passaged bovine spongiform encephalopathy prions to transgenic mice expressing elk prion protein
Q91588784Unique Structural Features of Mule Deer Prion Protein Provide Insights into Chronic Wasting Disease
Q40168614Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells.
Q35420475White-tailed deer are susceptible to the agent of sheep scrapie by intracerebral inoculation

Search more.